<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/mnpr" ></link>
<id>urn:uuid:3e33dc15-f2d6-014a-8b65-cdfd70f714d7</id>
<updated>2026-04-22T01:48:57-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>MNPR: ROBINSON CHANDLER (CEO,DIR) Acquired (JB) 6,732 Shares of MONOPAR THERAPEUTICS for $0.00 on 3/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6378574" ></link>
<id>urn:uuid:d8a99a30-e953-355a-0086-c4ae257e0137</id>
<updated>2026-04-02T15:03:36-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
<entry>
<title>MNPR: ROBINSON CHANDLER (CEO,DIR) Disposed (JS) 1,972 Shares of MONOPAR THERAPEUTICS for $54.79 on 3/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6378575" ></link>
<id>urn:uuid:e06b3590-ad5e-9895-c580-3de37e49884c</id>
<updated>2026-04-02T15:03:36-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
<entry>
<title>MNPR: CITTADINE ANDREW (COO) Acquired (JB) 3,514 Shares of MONOPAR THERAPEUTICS for $0.00 on 3/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6378577" ></link>
<id>urn:uuid:de38ca68-5f1e-8f38-abe9-b39fe9b56fdb</id>
<updated>2026-04-02T15:03:03-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
<entry>
<title>MNPR: CITTADINE ANDREW (COO) Disposed (JS) 1,571 Shares of MONOPAR THERAPEUTICS for $54.79 on 3/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6378578" ></link>
<id>urn:uuid:1b0e7b59-2a6c-e1f3-a2dc-e76a86b9a254</id>
<updated>2026-04-02T15:03:03-04:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
<entry>
<title>MNPR: RODRIGUEZ SUSAN (O) Filed a Form 3, Becoming a Registered Insider at MONOPAR THERAPEUTICS With Initial  Holdings of 0</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6351888" ></link>
<id>urn:uuid:39693ccd-b572-d724-886e-570cad62b11f</id>
<updated>2026-03-04T17:25:00-05:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
<entry>
<title>MNPR: ROBINSON CHANDLER (CEO,DIR) Acquired (JB) 62,815 Shares of MONOPAR THERAPEUTICS for $0.00 on 1/28</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6315138" ></link>
<id>urn:uuid:5310b442-0087-b523-69a4-3c36f347a590</id>
<updated>2026-01-30T14:31:04-05:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
<entry>
<title>MNPR: ROBINSON CHANDLER (CEO,DIR) Acquired (JB) 8,724 Shares of MONOPAR THERAPEUTICS for $0.00 on 12/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6300461" ></link>
<id>urn:uuid:5621e56f-cbd6-f855-c3b7-4c13c52e0445</id>
<updated>2026-01-05T15:46:21-05:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
<entry>
<title>MNPR: ROBINSON CHANDLER (CEO,DIR) Disposed (JS) 2,558 Shares of MONOPAR THERAPEUTICS for $65.30 on 12/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6300462" ></link>
<id>urn:uuid:9e3b5772-90f7-f5de-f3bd-63ebdf4cad2b</id>
<updated>2026-01-05T15:46:21-05:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
<entry>
<title>MNPR: CITTADINE ANDREW (COO) Acquired (JB) 4,326 Shares of MONOPAR THERAPEUTICS for $0.00 on 12/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6300464" ></link>
<id>urn:uuid:a9f3f91d-0a80-99ae-a3b0-89b87b49c273</id>
<updated>2026-01-05T15:45:58-05:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
<entry>
<title>MNPR: CITTADINE ANDREW (COO) Disposed (JS) 1,889 Shares of MONOPAR THERAPEUTICS for $65.30 on 12/31</title>
<link href="http://www.insiderinsights.com/company/mnpr/monopar-therapeutics/id-6300465" ></link>
<id>urn:uuid:71bee7e3-c82b-04a2-f65e-8b17f85f536f</id>
<updated>2026-01-05T15:45:58-05:00</updated>
<summary type="html" ><![CDATA[MONOPAR THERAPEUTICS (MNPR). Recent Price: $56.22. Mkt Cap:376.2mm. 10D Vol: 209,220]]></summary>
</entry>
</feed>